Skip to main content
Clinical Trials/CTRI/2017/08/009462
CTRI/2017/08/009462
Completed
Phase 4

An evaluation of procedural sedation techniques in Duchenne Muscular Dystrophy patients undergoing stem cell therapy

TMMC AND LTMGH0 sites54 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- DUCHENNE MUSCULAR DYSTROPHY PATIENTS ASA 1 AND 2Health Condition 2: G132- Systemic atrophy primarily affecting the central nervous system in myxedema
Sponsor
TMMC AND LTMGH
Enrollment
54
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 30, 2015
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
TMMC AND LTMGH

Eligibility Criteria

Inclusion Criteria

  • Patients of DMD undergoing procedural sedation techniques
  • Age more than 5years

Exclusion Criteria

  • 1\) unwilling for consent
  • 2\) patient not requiring any sort of sedation
  • 3\) patient needing general anaesthesia and assisted ventilation with or without tracheal intubation due to any reason

Outcomes

Primary Outcomes

Not specified

Similar Trials